Rob Stein

Pfzier-BioNTech and Moderna are asking the Food and Drug Administration to authorize the new omicron boosters for young children.

After virtually disappearing for the last two years, there are troubling clues that the flu could come roaring back this year, to cause trouble alongside COVID.

Biden's comments — made as officials try to convince Americans to get a new booster shot and the White House seeks $22 billion in new COVID funding — were "unfortunate," several epidemiologists said.

President Biden says the pandemic "is over," but public health experts, epidemiologists, infectious disease researchers and others strongly disagree, saying his remarks endanger efforts to save lives.

How has the rollout of the new COVID-19 vaccine boosters gone so far? Shots are plentiful, waits are short, but demand is uncertain.

It's a strange moment in the pandemic. For most vaccinated people, the risk of severe illness has gone way down. But hundreds are dying of COVID-19 every day. So how dangerous is the virus now?

They argue the threat posed by COVID has lessened because of preexisting immunity and access to treatment. Plus, some deaths may be incorrectly blamed on COVID. Others caution it's too soon to tell.

The COVID-19 vaccine strategy may be shifting toward Americans getting yearly vaccinations, like many do with annual flu shots.

New COVID-19 vaccine boosters designed to combat recent subvariants of the coronavirus are being made available to people over 12 years old. We have some guidance on who should get one and when.

CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.

The FDA is authorizing new booster shots to protect people against another surge of omicron infections this fall and winter.

The Food and Drug Administration authorized the first updated COVID-19 vaccines since the pandemic began — boosters targeted at the omicron variant.

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

The Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.

Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.

The Food and Drug Administration's decision against allowing more people to get second boosters has left many younger adults in limbo and angry.

The Biden administration is scrapping plans to offer COVID boosters for people under 50 this summer. Instead officials will push for an earlier release of the next generation boosters in the fall.

Evusheld, a course of injected antibodies, helps protect people with weak immune systems for up to six months. The government is making it available through pharmacies and individual providers.

The Biden administration may scrap plans to expand eligibility for second boosters to younger adults. Instead, it's trying to speed up the next generation of boosters targeting the omicron variant.

President Biden's COVID infection underscores a new surge of the pandemic, with another highly contagious virus strain and a federal scramble to provide more boosters to try to protect people.